Our psychiatry team offers a wholistic, integrative, interventional experience and treatment solution. Our customized and supportive approach is geared towards maximizing successful outcomes and symptom reduction.
We manage and treat the following conditions.
MOOD DISORDERS: Depression, Bipolar, and Disruptive Mood Dysregulation Disorders
ANXIETY DISORDERS: Generalized Anxiety, Social anxiety, Panic, Obsessive compulsive disorder, PTSD, Agoraphobia, Separation anxiety, Phobias, Selective Mutism, and School Refusal
DISRUPTIVE DISORDERS: ADHD, Oppositional Defiant Disorder, and Conduct Disorder.
DEVELOPMENT DISORDERS: Autism Spectrum, Sensory Integration, and Social communication Disorders
SLEEP DYSREGULATION: Insomnia, Night Terrors, Nightmares, Circadian-Rhythm Disorders.
IMPULSE CONTROL: Intermittent Explosive Disorder, Trichotillomania (hair pulling), Hoarding, Excoriation Disorder (Skin-Picking).
PERSONALITY DISORDERS: Borderline PD, OCPD, and others
RELATIONSHIP CHALLENGES: Marriage, Couples, Family, Parenting, Grief, and others
SECONDARY SUBSTANCE ABUSE: Diagnosis Only, detox and maintenance services are referred out
Transcranial Magnetic Stimulation (TMS) has been around for many decades and was only available at academic institutions for research and severe clinical cases. But ever since the FDA cleared and approved TMS for use in the general public for the treatment of depression and other conditions back in 2008, there has been a rapidly growing interest to use TMS as a reliable adjunctive or replacement treatment for depression and other conditions.
What has been even more exciting in recent years is the adoption of EEG data to provide a greater customization of TMS to further optimize brain response and healing.
Hence, Lighthouse Psychiatry is proud to be an exclusive provider of Advanced EEG-guided TMS (MeRT). This innovative technology can be an effective adjunctive treatment for many conditions, including depression, anxiety, autism (ASD), PTSD, concussion, traumatic brain injury, dementia, and mild cognitive impairment.
Magnetic e-Resonance Therapy (MeRT) is an advanced application of "standard" TMS. As of 2022, the FDA has only cleared TMS for the treatment of depression. Hence, insurance will only cover depression treatment. Application of TMS for other diagnoses are considered "off-label" and will not be covered by insurance.
We are thrilled to bring Wave Neuroscience's proprietary MeRT TMS technology to Arizona for the first time. Using a customized MagVenture TMS and quantitative EEG data, MeRT generates a personalized treatment algorithm to optimize brain healing.
ADHD is a complex condition that can often times get misdiagnosed and/or is a co-morbid condition coupled with other pervasive psychiatric conditions. Hence, it is important to diagnose ADHD correctly and accurately.
Using the most innovative and objective tool available, we adopted the QB Tech ADHD Testing module to diagnose ADHD, as well as, decipher the specific area of issues needed to address. The QB Test has a 84% sensitivity and 87% specificity, which is more accurate than most ADHD screening tools.
This a more accurate diagnosis, our clinicians are able to better manage the symptoms, as well as, provide a more effective treatment strategy.
Ketamine is a safe medication that has been widely used for decades since 1970s as an anesthetic in both children and adults.
Not unlike other anesthetics, ketamine has been used illegally for recreational use. Abuse of ketamine can be very dangerous and potentially lethal, as is the case with alcohol and narcotic medications.
That said, when used responsibility by trained clinicians, ketamine can be an extremely valuable option with a wide safety margin to treat a diverse range of conditions, including depression, anxiety, PTSD, trauma, OCD, pain, and suicidal ideation. In fact, the doses used for treatment of psychiatric and mental disorders are well below what is generally used for surgical procedures to anesthetize a patient.
HOW DOES KETAMINE WORK?
Biochemically, ketamine interacts with the NMDA receptor to produce anesthetic effects. It interacts with DA receptors to reduce dopamine deficiency in brain circuits involving the hippocampus and other brain nuclei. Addition, it interacts with the AMPA receptor to produce antidepressant effects. Although the specific mechanism of action of ketamine is still not fully understood by scientists and researchers, it is collectively believed ketamine targets gene expression and protein manufacture in certain important brain pathways or circuits, rather than directly targeting neurotransmitters. It rapidly activates a biochemical pathway associated with synaptic plasticity, the mTOR pathway, by increasing expression of a gene encoding the protein BDNF, which gets the m-TOR pathway going. Hence, activation of this pathway leads to increased number of new synapses in targeted brain regions leading to global restoration of brain synapses, both structurally and functionally, that may have been damaged by a chronically ill brain.
OPTIMIZING YOUR BRAIN'S MITOCHONDRIA, THE PRIMARY SOURCE OF ENERGY
TITAN-IR, a new innovative device, utilizes a patent pending, full frequency, multi-wavelength infrared technology to stimulate the pre-frontal cortex (PFC), an area of the brain known impact mood, cognition, and wellness.
Research has shown that transcranial photobiomodulation (tPBM) may increase the brain’s blood circulation, oxygen use, and metabolic activity.
These aspects have been clinically shown to boost mitochondria function in neurons which may help protect neurons from oxidative stress and may help maintain healthy levels of neuronal connectivity.
Through our exclusive partnership with innovative technology company Medify Inc, we are excited to bring this unique technology to our patients and the community we serve. This technology, not only help those who are working through mental health challenges, but it also is a great resource to improve and enhance overall brain performance and mental acuity.